CD8A and COVID-19: Additionally, a smaller number of biopsies (COVID-19 n = 5, controls n = 6) were analyzed for the expression of ACE2 and TMPRSS2 as mediators of virus entry as well as for the expression of EpCAM, CD8α, CD31, and CD163.